Logo
x

Search category

Subscribe Now

Eosinophilic Asthma

GSK's Nucala Receives Health Canada's Approval for Severe Eosinophilic Asthma in Children and Adolescents

GSK's Nucala Receives Health Canada's Approval for Severe Eosinophilic Asthma in Children and Adolescents

  • March 17, 2020
GSK's Nucala (mepolizumab) Receives European Commission Approval for Self-Administration in Severe Eosinophilic Asthma

GSK's Nucala (mepolizumab) Receives European Commission Approval for Self-Administration in Severe Eosinophilic Asthma

  • August 2, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.